Видео с ютуба Fda Cber Director

FDA Leadership Update: Meet Dr. Tracy Beth Høeg, New Acting Director of CDER

FDA Approves Updated COVID-19 Vaccines Amid Controversy: What You Need to Know

FDA Direct: Catching Up on Agency Reforms

Is PRP a Drug When It’s Activated? | Understanding FDA, CBER, and Orthobiologic Regulations

A Look at FDA's Drug Review Reset

КРИТИЧНОЕ ЧТЕНИЕ директора FDA: Обзор книги «Злокачественная» для инвесторов в биотехнологии и кл...

Dr. Vinay Prasad Keynote Address - NORD Scientific Symposium

FDA-NIH 2024 | D1S10 - CBER’s CMC Considerations for Early Phase Studies of Cell and Gene Therapy...

FDA-NIH 2024 | D1S08 - CBER’s Manufacturers Assistance and Technical Training Branch (MATTB)...

FDA's Vinay Prasad Reveals New Stricter COVID Vaccine Approval Standards in Leaked Memos

Dissecting the Direction of CDER and CBER with Paul Kim

FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA: CBER Q&A Panel

FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA: CBER Presentations

Shocking FDA Shakeup: Vinay Prasad Out — Huge Impact For CAPR & PGEN

FDA CBER主任 Vinay Prasad 离职，从FDA人事变动聊三个关于美国FDA的故事

Lilly trumpets heart health data with Mounjaro #news #pharmanews #healthcarenews #lifesciences

Watch CNBC's full interview with FDA Commissioner Dr. Marty Makary

FDA CBER Cell Therapies and Tissue-Based Products Workshop: Welcome and Opening Remarks

FDA CBER Cell Therapies Workshop: Closing - Insights and Remarks from Keynote Speaker

Center Director’s Decision Memo